Stay updated on Letetresgene AutoLeucel in Myxoid/Round Cell Liposarcoma Clinical Trial

Sign up to get notified when there's something new on the Letetresgene AutoLeucel in Myxoid/Round Cell Liposarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Letetresgene AutoLeucel in Myxoid/Round Cell Liposarcoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study completion date for the clinical trial evaluating Letetresgene autoleucel in participants with advanced myxoid/round cell liposarcoma.
    Difference
    0.1%
    Check dated 2024-06-06T14:33:54.000Z thumbnail image
  6. Check
    20 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying age, diagnosis, and other health conditions required for study enrollment. Previously, this section had no information provided.
    Difference
    28%
    Check dated 2024-05-22T20:59:27.000Z thumbnail image
  7. Check
    42 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:49:24.000Z thumbnail image

Stay in the know with updates to Letetresgene AutoLeucel in Myxoid/Round Cell Liposarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Letetresgene AutoLeucel in Myxoid/Round Cell Liposarcoma Clinical Trial page.